Data / Drug companies / Jones Healthcare Group - Packaging Services, Inc
Jones Healthcare Group - Packaging Services, Inc: 11 products in the FDA NDC directory, labeler code 67414
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Jones Healthcare Group - Packaging Services, Inc (labeler code 67414) lists 11 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 11 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 30, 2026.
The request: Watch Jones Healthcare Group - Packaging Services, Inc (FDA labeler code 67414): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 67414
- Products in commercial distribution
- 11
- Packages
- 20
- Finished drugs by generic name
- 8
- Prescription products
- 0
- Over the counter products
- 11
- Flagged as original packager
- 10 of 10 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- July 1, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 6 | 54.5% |
| Generic drugs (ANDA) | 3 | 27.3% |
| New drug applications (NDA) | 1 | 9.1% |
| Drugs for further processing | 1 | 9.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 11 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 6 | 54.5% |
| Tablet | 2 | 18.2% |
| Capsule | 2 | 18.2% |
| Tablet, coated | 1 | 9.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Pepcid Complete Dual Action Berry Flavor | 67414-700 | Tablet | New drug applications (NDA) | July 30, 2026 |
| Zyrtec Allergy Cetirizine HCl | 67414-013 | Capsule | Generic drugs (ANDA) | June 30, 2026 |
| Zyrtec Allergy Cetirizine HCl | 67414-012 | Capsule | Generic drugs (ANDA) | June 30, 2026 |
| Tylenol PM Extra Strength | 67414-608 | Tablet, film coated | Over the counter monograph drugs | January 25, 2018 |
| Tylenol Sinus Severe | 67414-507 | Tablet, coated | Over the counter monograph drugs | January 25, 2018 |
| Tylenol Cold Plus Flu Severe Severe | 67414-402 | Tablet, film coated | Over the counter monograph drugs | January 25, 2018 |
| Tylenol Extra Strength Caplet | 67414-449 | Tablet | Over the counter monograph drugs | January 24, 2018 |
| Excedrin migraine | 67414-239 | Tablet, film coated | Over the counter monograph drugs | January 24, 2018 |
| Benadryl Allergy Ultratab | 67414-226 | Tablet, film coated | Over the counter monograph drugs | January 24, 2018 |
| Acetaminophen, aspirin (nsaid), and caffeine | 67414-200 | Tablet, film coated | Drugs for further processing | January 24, 2018 |
| Motrin IB | 67414-240 | Tablet, film coated | Generic drugs (ANDA) | July 1, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.